Skip to content
Collegium Pharmaceutical, Inc. logo

Collegium Pharmaceutical, Inc.

COLLNASDAQStock Fundamentals

Collegium Pharmaceutical, Inc. is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Vikram Karnani, with a market cap of $1.1B.

Market Cap$1.1B
Employees197.0
CEOVikram Karnani
United States of America flag
CountryUnited States of America
Healthcare
Drug Manufacturers - Specialty & Generic
Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026
View report
Next EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Collegium Pharmaceutical, Inc. logo

Collegium Pharmaceutical, Inc. FAQ

Common questions about Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical, Inc. (COLL) has a market capitalization of $1.1B and trades on NASDAQ.

Collegium Pharmaceutical, Inc. has approximately 197 employees.